Sagamore Childrens Psychiatric Center Intensive Day Trt Program

If you are looking at Sagamore Childrens Psychiatric Center Intensive Day Trt Program in Macon, GA, the basics worth knowing up front: The facility's programming is outpatient (Outpatient, MAT), not residential. This page walks through the questions that tend to matter most to families weighing a specific program.

Care levels at Sagamore Childrens Psychiatric Center Intensive Day Trt Program

Sagamore Childrens Psychiatric Center Intensive Day Trt Program is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

Sagamore Childrens Psychiatric Center Intensive Day Trt Program operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to Sagamore Childrens Psychiatric Center Intensive Day Trt Program, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.